Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine extended release for painful diabetic neuropathy
2004-005024-40Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic neuropathy and diabetic polyneuropathy (DPN) comparing Lamotrigine extended release with Placebo (2 arms). Primary endpoint: Change in pain intensity score from baseline. Started Mar 2005; status: completed.
02
Drugs
lamotrigine
03
Conditions
diabetic neuropathydiabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2004-005024-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005024-40.